世界のバイオチップ市場予測2019-2028

【英語タイトル】GLOBAL BIOCHIPS MARKET FORECAST 2019-2028

Inkwood Researchが出版した調査資料(INK20AG027)・商品コード:INK20AG027
・発行会社(調査会社):Inkwood Research
・発行日:2020年5月
・ページ数:325
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:通信
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥260,000見積依頼/購入/質問フォーム
Multi LicenseUSD3,000 ⇒換算¥312,000見積依頼/購入/質問フォーム
Enterprisewide PriceUSD4,500 ⇒換算¥468,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、バイオチップの世界市場について調査を行い、調査手法、エグゼクティブサマリー、市場動向、主要分析、種類別(DNAチップ、ラボオンチップ、タンパク質チップ、その他)分析、基板材料別分析、エンドユーザー別分析、地域別分析、企業情報などをまとめております。
・調査手法
・エグゼクティブサマリー
・市場動向
・主要分析
・バイオチップの世界市場規模:種類別(DNAチップ、ラボオンチップ、タンパク質チップ、その他)
・バイオチップの世界市場規模:基板材料別
・バイオチップの世界市場規模:エンドユーザー別
・バイオチップの世界市場規模:地域別
・企業情報



























【レポートの概要】

KEY FINDINGS
The global biochips market is projected to register a CAGR of 13.41% during the forecast period of 2019-2028. Increasing incidences of chronic diseases, rising investments in medical and healthcare research, growth in personalized medicine, developing software and service sectors in proteomics and genomics, and rapidly growing use of point-of-care testing diagnosis are the principal factors contributing to the global market growth.

MARKET INSIGHTS
Biochip is a microchip used to simultaneously analyze a panel of related tests in a single sample producing a patient’s profile. The patient profile can be used in diagnosis, disease screening, monitoring disease progression, or monitoring treatment. Biochips play an important role in molecular diagnostics, and their application in point-of-care diagnosis is expected to facilitate the development of personalized medicines. Emphasis on personalized medicine-based analytics is adding growth to the biochips market. Personalized medicines offer patients an early diagnosis, optimal treatments, risk assessments, low-cost improved healthcare. The success of personalized medicine depends upon information and record of reliable and accurate diagnostics.
The complexity of biological systems is a major challenge for the biochips market. The large-scale testing on a single chip creates complexity. Lab on a chip in the type segment collected the largest revenue share in 2019. Biotechnology and pharmaceutical companies are the fastest-growing end-users. There is a sustainable competitive advantage through innovations between companies in the market.

REGIONAL INSIGHTS
The global biochips market is surveyed geographically by segmenting into regions of Europe, Asia Pacific, North America, and the Rest of the World. The region of North America dominated the market in 2019 in terms of revenue, due to growing awareness about biochips and their widespread applications in various fields such as personalized medicine, clinical diseases, agri-genomics, and others.

COMPETITIVE INSIGHTS
The biochips market is highly competitive, dominated by well-established companies, and also multiple new players holding the majority of market share. Some of the participants competing in the market are Abbott Laboratories Inc, F. Hoffmann-La Roche Ltd, Randox Laboratories Ltd, GE Healthcare, Merck KGaA, etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

【レポートの目次】

1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. PARENT MARKET ANALYSIS: GENOMICS AND PROTEOMICS MARKET
3.2. DEVELOPMENT OF BIOCHIPS
3.3. MARKET DEFINITION
3.4. KEY DRIVERS
3.4.1. RISING INCIDENCES OF CHRONIC DISEASES
3.4.2. GROWING INTEREST IN PERSONALIZED MEDICINES
3.4.3. APPLICATION OF PROTEOMICS AND GENOMICS IN CANCER RESEARCH
3.4.4. RAPIDLY GROWING USE OF POINT-OF-CARE TESTING DIAGNOSTICS
3.5. KEY RESTRAINTS
3.5.1. HIGH INSTRUMENTATION COST
3.5.2. LACK OF AWARENESS AMONG COMMON PEOPLE ABOUT BIOCHIP TECHNOLOGY
3.5.3. AVAILABILITY OF ALTERNATIVE TECHNOLOGY: NEXT GENERATION SEQUENCING (NGS) TECHNOLOGY
3.5.4. COMPLEXITY OF BIOLOGICAL SYSTEMS
3.5.5. LACK OF COMMON REGULATORY STANDARDS
4. KEY ANALYTICS
4.1. IMPACT OF COVID-19 ON BIOCHIPS
4.2. KEY INVESTMENT INSIGHTS
4.3. PORTER’S FIVE FORCE ANALYSIS
4.3.1. BUYER POWER
4.3.2. SUPPLIER POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. OPPORTUNITY MATRIX
4.5. VENDOR LANDSCAPE
4.6. VALUE CHAIN ANALYSIS
4.6.1. RESEARCH & DEVELOPMENT
4.6.2. RAW MATERIALS
4.6.3. MANUFACTURING
4.6.4. WHOLESALERS/RETAILERS/DISTRIBUTORS
4.6.5. END-USER
4.7. KEY BUYING CRITERIA
4.7.1. COST
4.7.2. APPLICATIONS
4.7.3. PRODUCT TYPE
4.8. REGULATORY FRAMEWORK
5. MARKET BY TYPE
5.1. DNA CHIPS
5.1.1. AGRICULTURAL BIOTECHNOLOGY
5.1.2. CANCER DIAGNOSIS & TREATMENT
5.1.3. DRUG DISCOVERY
5.1.4. GENE EXPRESSION
5.1.5. GENOMICS
5.1.6. SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING
5.1.7. OTHER DNA CHIPS
5.2. LAB ON A CHIP
5.2.1. CLINICAL DIAGNOSTICS
5.2.2. DRUG DISCOVERY
5.2.3. GENOMICS
5.2.4. POINT OF CARE & IN VITRO DIAGNOSIS
5.2.5. PROTEOMICS
5.2.6. OTHER LAB ON A CHIP
5.3. PROTEIN CHIPS
5.3.1. DIAGNOSTICS
5.3.2. DRUG DISCOVERY
5.3.3. EXPRESSION PROFILING
5.3.4. HIGH THROUGHPUT SCREENING
5.3.5. PROTEOMICS
5.3.6. OTHER PROTEIN CHIPS
5.4. OTHER TYPES
5.4.1. CELL ARRAYS
5.4.2. TISSUE ARRAYS
6. MARKET BY SUBSTRATE MATERIALS
6.1. GLASS
6.2. POLYMERS
6.3. SILICON
6.4. OTHER SUBSTRATE MATERIALS
7. MARKET BY END-USER
7.1. BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
7.2. HOSPITALS AND DIAGNOSTICS CENTERS
7.3. ACADEMIC AND RESEARCH INSTITUTES
8. GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1. UNITED STATES
8.1.2. CANADA
8.2. EUROPE
8.2.1. UNITED KINGDOM
8.2.2. GERMANY
8.2.3. FRANCE
8.2.4. ITALY
8.2.5. RUSSIA
8.2.6. BELGIUM
8.2.7. POLAND
8.2.8. REST OF EUROPE
8.3. ASIA PACIFIC
8.3.1. CHINA
8.3.2. JAPAN
8.3.3. INDIA
8.3.4. SOUTH KOREA
8.3.5. INDONESIA
8.3.6. THAILAND
8.3.7. VIETNAM
8.3.8. AUSTRALIA & NEW ZEALAND
8.3.9. REST OF ASIA PACIFIC
8.4. REST OF WORLD
8.4.1. LATIN AMERICA
8.4.2. MIDDLE EAST & AFRICA
9. COMPANY PROFILES
9.1. ABBOTT LABORATORIES INC
9.2. AGILENT TECHNOLOGIES INC
9.3. BIOCHAIN INSTITUTE INC
9.4. BIOMÉRIEUX SA
9.5. BIO-RAD LABORATORIES INC
9.6. CEPHEID
9.7. CYBRDI INC
9.8. F HOFFMANN-LA ROCHE LTD
9.9. FLUIDIGM CORPORATION
9.10. GE HEALTHCARE
9.11. ILLUMINA INC
9.12. MERCK KGAA
9.13. PERKINELMER INC
9.14. RANDOX LABORATORIES LTD
9.15. THERMO FISHER SCIENTIFIC INC

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - BIOCHIPS
TABLE 2: ESTIMATED NUMBER OF NEW CANCER CASES & ESTIMATED DEATHS DUE TO CANCER IN 2018
TABLE 3: REGULATORY FRAMEWORK
TABLE 4: GLOBAL BIOCHIPS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 5: GLOBAL BIOCHIPS MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 6: GLOBAL DNA CHIPS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 7: GLOBAL DNA CHIPS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 8: GLOBAL BIOCHIPS MARKET, BY DNA CHIPS, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 9: GLOBAL BIOCHIPS MARKET, BY DNA CHIPS, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 10: GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 11: GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 12: GLOBAL CANCER DIAGNOSIS & TREATMENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 13: GLOBAL CANCER DIAGNOSIS & TREATMENT MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 14: GLOBAL DRUG DISCOVERY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 15: GLOBAL DRUG DISCOVERY MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 16: GLOBAL GENE EXPRESSION MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 17: GLOBAL GENE EXPRESSION MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 18: GLOBAL GENOMICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 19: GLOBAL GENOMICS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 20: GLOBAL SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 21: GLOBAL SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 22: GLOBAL OTHER DNA CHIPS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 23: GLOBAL OTHER DNA CHIPS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 24: GLOBAL LAB ON A CHIP MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 25: GLOBAL LAB ON A CHIP MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 26: GLOBAL BIOCHIPS MARKET, BY LAB ON A CHIP, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 27: GLOBAL BIOCHIPS MARKET, BY LAB ON A CHIP, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 28: GLOBAL CLINICAL DIAGNOSTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 29: GLOBAL CLINICAL DIAGNOSTICS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 30: GLOBAL DRUG DISCOVERY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 31: GLOBAL DRUG DISCOVERY MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 32: GLOBAL GENOMICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 33: GLOBAL GENOMICS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 34: GLOBAL POINT OF CARE & IN VITRO DIAGNOSIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 35: GLOBAL POINT OF CARE & IN VITRO DIAGNOSIS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 36: GLOBAL PROTEOMICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 37: GLOBAL PROTEOMICS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 38: GLOBAL OTHER LAB ON A CHIP MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 39: GLOBAL OTHER LAB ON A CHIP MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 40: GLOBAL PROTEIN CHIPS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 41: GLOBAL PROTEIN CHIPS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 42: GLOBAL BIOCHIPS MARKET, BY PROTEIN CHIPS, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 43: GLOBAL BIOCHIPS MARKET, BY PROTEIN CHIPS, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 44: GLOBAL DIAGNOSTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 45: GLOBAL DIAGNOSTICS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 46: GLOBAL DRUG DISCOVERY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 47: GLOBAL DRUG DISCOVERY MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 48: GLOBAL EXPRESSION PROFILING MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 49: GLOBAL EXPRESSION PROFILING MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 50: GLOBAL HIGH THROUGHPUT SCREENING MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 51: GLOBAL HIGH THROUGHPUT SCREENING MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 52: GLOBAL PROTEOMICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 53: GLOBAL PROTEOMICS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 54: GLOBAL OTHER PROTEIN CHIPS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 55: GLOBAL OTHER PROTEIN CHIPS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 56: GLOBAL OTHER TYPES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 57: GLOBAL OTHER TYPES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 58: GLOBAL BIOCHIPS MARKET, BY OTHER TYPES, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 59: GLOBAL BIOCHIPS MARKET, BY OTHER TYPES, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 60: GLOBAL CELL ARRAYS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 61: GLOBAL CELL ARRAYS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 62: GLOBAL TISSUE ARRAYS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 63: GLOBAL TISSUE ARRAYS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 64: PROPERTIES OF BIOCHIPS SUBSTRATE MATERIALS
TABLE 65: GLOBAL BIOCHIPS MARKET, BY SUBSTRATE MATERIALS, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 66: GLOBAL BIOCHIPS MARKET, BY SUBSTRATE MATERIALS, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 67: GLOBAL GLASS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 68: GLOBAL GLASS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 69: GLOBAL POLYMERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 70: GLOBAL POLYMERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 71: GLOBAL SILICON MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 72: GLOBAL SILICON MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 73: GLOBAL OTHER SUBSTRATE MATERIALS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 74: GLOBAL OTHER SUBSTRATE MATERIALS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 75: GLOBAL BIOCHIPS MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 76: GLOBAL BIOCHIPS MARKET, BY END-USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 77: GLOBAL BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 78: GLOBAL BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 79: GLOBAL HOSPITALS AND DIAGNOSTICS CENTERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 80: GLOBAL HOSPITALS AND DIAGNOSTICS CENTERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 81: GLOBAL ACADEMIC AND RESEARCH INSTITUTES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 82: GLOBAL ACADEMIC AND RESEARCH INSTITUTES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 83: GLOBAL BIOCHIPS MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 84: GLOBAL BIOCHIPS MARKET, BY GEOGRAPHY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 85: NORTH AMERICA BIOCHIPS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 86: NORTH AMERICA BIOCHIPS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 87: EUROPE BIOCHIPS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 88: EUROPE BIOCHIPS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 89: ASIA PACIFIC BIOCHIPS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 90: ASIA PACIFIC BIOCHIPS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 91: REST OF WORLD BIOCHIPS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 92: REST OF WORLD BIOCHIPS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)


★調査レポート[世界のバイオチップ市場予測2019-2028] (コード:INK20AG027)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のバイオチップ市場予測2019-2028]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆